<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1019">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05147883</url>
  </required_header>
  <id_info>
    <org_study_id>EFEXQULS</org_study_id>
    <nct_id>NCT05147883</nct_id>
  </id_info>
  <brief_title>The Effect of Exercise on Quality of Life, Sleep Quality and Anxiety in Patients With Prediabetes (EFEXQULS)</brief_title>
  <acronym>EFEXQULS</acronym>
  <official_title>The Effect of Exercise on Quality of Life, Sleep Quality and Anxiety in Patients With Prediabetes (EFEXQULS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the effect of exercise on quality of life, sleep&#xD;
      quality and anxiety in patients with prediabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized controlled studies are needed to examine the effects of exercise on sleep quality,&#xD;
      quality of life, anxiety and depression in patients with prediabetes.&#xD;
&#xD;
      The aim of this study is to determine the effect of exercise on quality of life, sleep&#xD;
      quality and anxiety in patients with prediabetes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score of Quality of Life</measure>
    <time_frame>1 week</time_frame>
    <description>Quality of Life evaluated with Health-Related Quality of Life (HRQOL) Survey</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>1 week</time_frame>
    <description>Sleep Quality evaluated with Pitssburgh Sleep Quality Index (PSQI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>1 week</time_frame>
    <description>Anxiety evaluated with Hospital Anxiety Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>1 week</time_frame>
    <description>Depression evaluated with Hospital Anxiety Depression Scale (HADS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>PreDiabetes</condition>
  <condition>Physical Inactivity</condition>
  <condition>Quality of Life</condition>
  <condition>Sleep</condition>
  <condition>Anxiety</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be given an aerobic exercise program for 1 hour, 3 days a week for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention will be applied to the patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Patients will be given an aerobic exercise program for 1 hour, 3 days a week for 12 weeks</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-59 years old&#xD;
&#xD;
          -  Living a sedentary life (physical activity below 300 kcal/day will be evaluated with&#xD;
             the Minnesota Leisure Physical Activity Questionnaire)&#xD;
&#xD;
          -  Those who have sufficient motivation to participate in the exercise program (will be&#xD;
             evaluated by a one-on-one interview by the researchers)&#xD;
&#xD;
          -  Those diagnosed with prediabetes by oral glucose tolerance test and/or HbA1c&#xD;
             measurement will be included.&#xD;
&#xD;
          -  Being eligible to participate in an exercise program after a cardiac examination&#xD;
             (resting ECG and questioning of cardiac symptoms, advanced tests such as exercise ECG&#xD;
             test if necessary) performed by the physician&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Serious medical condition (for example, advanced malignancy or major neurological,&#xD;
             psychiatric or endocrine disease, respiratory failure, etc.) that would prevent the&#xD;
             person from participating in exercise training.&#xD;
&#xD;
          -  Having cardiovascular disease&#xD;
&#xD;
          -  Being diabetic&#xD;
&#xD;
          -  Receiving hormone replacement therapy&#xD;
&#xD;
          -  Life expectancy less than 1 year&#xD;
&#xD;
          -  HIV positivity&#xD;
&#xD;
          -  Substance use&#xD;
&#xD;
          -  Functional dependency&#xD;
&#xD;
          -  Cognitive weakness&#xD;
&#xD;
          -  Those who have other diseases that will affect the results of the study (respiratory&#xD;
             diseases, muscle diseases, etc.)&#xD;
&#xD;
          -  Those who use drugs or supplements that will affect the results of the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>18-59 years</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elif Yıldırım Ayaz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sultan Abdülhamid Training And Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elif Yıldırım Ayaz, M.D.</last_name>
    <phone>+905325148300</phone>
    <email>drelifyildirim@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sultan Abdülhamid Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <state>Uskudar</state>
        <zip>34366</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Elif Yıldırım Ayaz, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 23, 2021</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</investigator_affiliation>
    <investigator_full_name>Elif Yıldırım Ayaz</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>PreDiabetes</keyword>
  <keyword>Physical Inactivity</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Sleep</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

